skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

世界の薬事規制動向&情報を配信

Pink Sheet – US Election and New Administration Coverage

Stay informed of the latest news from the recent US election and understand how the shift in power will affect pharma regulatory and policy issues both within the United States and abroad. Pink Sheet takes you behind the US election headlines for analysis on the real impact you can expect to see on your business.

Topic us-election-2020

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Scrip: 世界の医...

39th Annual J.P. Morgan Healthcare Conference 2021

39th Annual J.P. Morgan Healthcare Conference 2021

Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

新型コロナウイルスワクチンの優先接種対象者:世界的な展開計画

新型コロナウイルス感染拡大が続く中、各国政府はワクチン開発に期待を寄せ、現在複数のワクチン候補が後期治験段階にあります。本ホワイトペーパーではワクチン開発の最新状況と共に、各国でのワクチン優先接種対象者の規模を推定します。

Topic Coronavirus vaccines

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Pharma Intelligence Insights – Outlook 2021 Report

Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.

Topic Outlook

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

With US Senate Wins In Georgia, Democrats Gain Path For Rx Price Reform, But It May Be Lower Priority

Warnock_Raphael_1200-USSenatorelect-5January2021

Razor-thin majorities in both chambers of Congress mean Democrats can’t enact a bold agenda, and the pandemic and attendant recession mean that the initial legislative focus won’t be on Rx issues.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

First In World COVID-19 Vaccine For Kids Below 12?

First In World COVID-19 Vaccine For Kids Below 12?

Could Serum Institute or Bharat Biotech be the first company to have a COVID-19 vaccine for children under 12 years of age? While Pfizer and Moderna have begun pediatric trials for children 12 years and above, Serum plans to begin testing its indigenous vaccine and Bharat Biotech its Covaxin in children under 12

Topic Coronavirus

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

UK Vaunts 'New Era' In Drug Approvals

PS2101_Pathway_To_Future_1494901280_1200

The UK regulator, the MHRA, has published guidance on its new integrated pathway for innovative drug approvals, which it says is intended to bring together partners including health technology assessment agencies, health care bodies and patient organizations to offer “sustained collaboration” with drug developers.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

How COVID-19 Defined 2020 For Biopharma

SP_Coronavirus_1643947495_1200

Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.

Topic Coronavirus

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問合せの際は下記メールアドレスまたは各営業スタッフまでご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
ファーマインテリジェンス
inquiry.jp@informa.com

*Omdia(ICT産業の情報)に関するお問い合わせはこちら
Contact_OmdiaJapan@omdia.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。